|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Land improvements and buildings | ||||||||||||||||||||
| Rental homes and improvements | ||||||||||||||||||||
| Furniture, fixtures and equipment | ||||||||||||||||||||
| Investment property | ||||||||||||||||||||
| Accumulated depreciation | ||||||||||||||||||||
| Investment property, net | ||||||||||||||||||||
| Cash, cash equivalents and restricted cash | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Inventory of manufactured homes | ||||||||||||||||||||
| Notes and other receivables, net (includes $207.8 and $183.7 at fair value, respectively, see Note 4) | ||||||||||||||||||||
| Collateralized receivables, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible Asset, Excluding Goodwill, after Accumulated Amortization | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Assets held for sale and discontinued operations, net (see Note 2) | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Secured debt | ||||||||||||||||||||
| Mortgage loans payable (see Note 7) | ||||||||||||||||||||
| Secured borrowings on collateralized receivables | ||||||||||||||||||||
| Total secured debt | ||||||||||||||||||||
| Unsecured debt | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Contract with Customer, Liability | ||||||||||||||||||||
| Accounts Payable and Accrued Liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Liabilities held for sale and discontinued operations, net (see Note 2) | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Temporary equity (see Note 8) | ||||||||||||||||||||
| Series D Preferred OP Units | ||||||||||||||||||||
| Series F Preferred OP Units | ||||||||||||||||||||
| Series G Preferred OP Units | ||||||||||||||||||||
| Total temporary equity (see Note 8) | ||||||||||||||||||||
| Shareholders’ Equity | ||||||||||||||||||||
| Common stock, $0.01 par value. Authorized: 360.0 shares; Issued and outstanding: 119.9 shares at September 30, 2026 and 123.5 shares at December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Distributions in excess of accumulated earnings | ||||||||||||||||||||
| Total SUI Shareholders’ Equity | ||||||||||||||||||||
| Common and preferred OP units | ||||||||||||||||||||
| Consolidated entities | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total Shareholders’ Equity | ||||||||||||||||||||
| Total Liabilities, Temporary Equity and Shareholders’ Equity | ||||||||||||||||||||
Loading...
